课题基金 / 基金详情

项目摘要

项目成果

JULIE Ann LEARY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本次竞争更新的主要目标集中在糖胺多糖的分离、纯化和完整的化学表征上,因为它与肝素和HS对各种炎性趋化因子的络合作用有关。建立了三种特异性类风湿关节炎相关趋化因子的糖胺多聚糖(GAG)结合体的分离、纯化和鉴定方法,并用离子迁移质谱(IM-MS)和CID-MS进行鉴定。GAG结合体与其对应的趋化因子的络合作用将用MS进行研究,单体、二聚体和四聚体组装用IM-MS测量。这些研究将与绝经前和绝经后年龄范围的类风湿性关节炎妇女血清中GAG的成分分析相结合,以确定HRT的健康益处及其与GAG成分的相关性。这三个特异靶是:特异靶1:人血清中的GAG组成,特异靶2:GAG文库与趋化因子的色谱制备、分离、鉴定和络合,以及特异靶3:趋化因子和GAG结合物的离子迁移率MS和X射线结晶学。建议的主要领域以这样一种方式交织在一起,即方法开发、生物技术和对生物相关系统的应用是将建议的研究捆绑在一起的紧密联系的要素。
英文摘要
DESCRIPTION (provided by applicant): The broad goal of this competing renewal focuses on glycosaminoglycan separation, purification and complete chemical characterization as it pertains to heparin and HS complexation to various inflammatory chemokines. Methods will be developed to separate, purify and identify glycosaminoglycan (GAG) binders of three specific Rheumatoid Arthritis associated chemokines using chromatography, ion mobility mass spectrometry (IM-MS) and CID-MS. Complexation of GAG binders to their chemokine counterparts will be investigated by MS with the monomer, dimer and tetramer assemblies measured using IM-MS. These studies will be paired with the compositional analysis of GAG in sera from women with Rheumatoid Arthritis in the pre- and postmenopausal age range to determine health benefits of HRT and its correlation with GAG composition. The three specific aims are: Specific Aim 1: GAG composition in Human Serum, Specific Aim 2: Chromatographic preparation, separation, identification and complexation of GAG libraries with Chemokines, and Specific Aim 3: Ion Mobility MS and X-ray crystallography of Chemokine and GAG binders. The major areas proposed are interwoven in such a way that methods development, biotechnology and application to biologically relevant systems are the cohesive elements that bind the proposed research together.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acquisition of A MALDI-TOF Mass Spectrometer
Acquisition of a Waters Xevo Q-ToF MS System
Thermo Finnigan LTQ-Orbitrap
CORE-- MASS SPECTROMETRY FACILITY
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: